However, a common 2903 bp intron deletion polymorphism of BIM leads to the preferential generation lack the BH3 domain and it may correlated with inferior response to TKI in CML patients [25]. The gene discussed is BCL2L11; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.